human hepatitis b immunoglobulin
PolandDrugs containing this active substance
-
The medicine is used for prophylactic protection against hepatitis B virus (HBV) infection. It is intended for newborns whose mothers are carriers of the HBs antigen, and for children weighing up to 50 kg who are at particular risk of infection in a hospital setting.
Form: solution for injection
Active substance Dosage human hepatitis b immunoglobulin 200 j.m. ATC: J06BB04
Manufacturer: Synthaverse S.A.
-
The medicine is used to provide immediate and long-term protection against hepatitis B virus. It is used in unvaccinated or under-vaccinated individuals who are exposed to infection, in liver transplant patients (to prevent re-infection), in newborns whose mothers are infected, and in individuals for whom the vaccine was not effective.
Form: solution for infusion
Active substance Dosage human hepatitis b immunoglobulin 50 j.m./ml ATC: J06BB04
Manufacturer: Biotest Pharma GmbH
-
The medicine is used to prevent the recurrence of hepatitis B virus after liver transplantation and to prevent infection in people who have had accidental contact with the virus, in patients undergoing hemodialysis, in newborns of mothers who are carriers of the virus, and in individuals for whom vaccination was not effective.
Form: solution for injection
Active substance Dosage human hepatitis b immunoglobulin 180 units ATC: J06BB04
Manufacturer: Kedrion S.p.A.